Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
The EMJ prides itself on being an international journal. Whilst submissions from the United Kingdom made up around 40% of our published work in 2022, we have readers from around the world and as an editorial team we encourage submissions from anywhere. Indeed, opening this month’s EMJ and looking at where publications have originated from does have a pleasingly international feel. It reads like the locations of top fashion boutiques; Milan, San Francisco, Boston, Melbourne (and Plymouth). This is the first time I recall that international emergency care research teams have outweighed UK based authors in an issue – fantastic stuff. So, let’s take a closer look at the diversity of material we have on offer.
This month we include three articles that explore very different aspects of head injury. In our Editor’s Choice, Alice Rogan and colleagues from New Zealand explore the role of serum S100B for ruling out intracranial pathology in mild traumatic brain injury. Looking back over the years the EMJ has published a few pieces of original research evaluating S100B, yet it has never made its way …
Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.
Competing interests None declared.
Provenance and peer review Not commissioned; internally peer reviewed.